Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
about
The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestationsThe role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatmentsDietary triggers in irritable bowel syndrome: Is there a role for glutenEfficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled TrialsEfficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to dateArtificial Sweeteners: A Systematic Review and Primer for GastroenterologistsDiagnosis and treatment of diarrhea-predominant irritable bowel syndromeDiagnosis and management of functional symptoms in inflammatory bowel disease in remissionGut microbiota role in irritable bowel syndrome: New therapeutic strategiesThe Overlap between Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity: A Clinical DilemmaGenetic epidemiology of irritable bowel syndromeIrritable bowel syndrome and chronic constipation: Fact and fictionIntestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanismsImpact of psychological stress on irritable bowel syndromeLinaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adultsThe clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D)Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoeaIBS-like symptoms in patients with ulcerative colitisEfficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysisThe spectrum of noncoeliac gluten sensitivityVisceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteasesAbdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in JapanEvaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.Mechanisms and efficacy of dietary FODMAP restriction in IBS.Abnormal accumulation of intestinal fluid following ingestion of an unabsorbable carbohydrate in patients with irritable bowel syndrome: an MRI study.Neuroimaging the brain-gut axis in patients with irritable bowel syndromeIrritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating.Perspective: An easier diagnosis.PREVALENCE OF SMALL INTESTINE BACTERIAL OVERGROWTH IN PATIENTS WITH GASTROINTESTINAL SYMPTOMS.A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome.Irritable bowel syndrome: the role of food in pathogenesis and management.Unclear abdominal discomfort: pivotal role of carbohydrate malabsorption.Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation.2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel SyndromeEarly response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies.Role of antispasmodics in the treatment of irritable bowel syndrome.Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome.Symptom pattern following a meal challenge test in patients with irritable bowel syndrome and healthy controls.
P2860
Q22001077-022962E1-641D-4891-8DF8-3C37D60F507DQ26739291-F601D9CE-808A-4E93-88D8-6718749B6062Q26739974-2D723552-8B53-4E13-98A3-A6D74C166482Q26740132-250D108C-FA5C-40C6-971A-78358141206FQ26744329-3F5C29AB-9215-4633-A721-45A165E323DDQ26765117-83FE7DC8-ECCD-4276-9381-0E8E0799F85DQ26765272-F12DBE63-523D-4DD4-BB2A-A2048A67578EQ26768264-357DCDED-F138-4461-B195-1C0CBC0EED2AQ26768550-EDF04530-FC88-4B4D-A746-9BE3F1794070Q26774181-A8B4220F-83E5-4E05-AD15-75D992FAA81BQ26777392-D37D8C93-4DE5-43D7-A68F-933F80010417Q26777547-EC3D2DEF-31A4-472F-8D4B-ECBEB5D30C34Q26828617-530266E8-0484-44A4-8DE0-8573A3F14CEEQ26830683-CC60E6AD-48B9-4374-8913-47D73EEA868DQ26853213-94813693-B61F-4D5B-9688-7CFC3B2C5E86Q27010449-1D76A559-77B3-4F8B-80E6-C4B1507578F9Q27024521-95FF13C5-C7D6-43A0-A1D8-7BCE047BB20FQ28081213-998DC3D0-FAFA-4E72-A3FE-3AF897F868C1Q28088663-3A22C441-80C5-44D2-8514-A7FB49C7FB71Q28244815-1AA65067-F2EA-4E30-B211-9DACD5848C2AQ28264246-EF9C9052-0BB7-4C97-91F7-8CD8D883664CQ28818844-5EFC152E-C75E-43CA-9947-66E3570BF229Q30382064-053DC809-A605-4EF7-8434-79D9AF727A08Q30565579-81A73AD5-44B7-4F63-B554-72A68741CCC7Q30738587-44E2F38E-AAEB-4B82-896E-1E429EB580EDQ30856790-01081EF8-0A82-4B94-8526-B8D9DEB8A8A7Q31093698-D093F715-FEFA-45FD-A94E-B4A24B9A23DDQ33463901-60C78D21-5188-4D0D-B03E-C70BBF3BC8AFQ33467973-52C6597D-941D-436F-B82F-0DC33F87EDB3Q33469988-15773F1A-66CA-4DD3-835E-18AFA172CBDCQ33470900-A1D2BCD6-2ED5-4520-A22A-988E6F2D6981Q33582170-FA185A08-ECCC-4BFE-B44F-05F5A0EB54AEQ33586822-A12EAF32-F9F6-4189-9248-1BB008F71DADQ33586854-51964A0A-DE30-4985-B4D2-341FA4AC24E8Q33619014-E633E8E8-A42D-44D2-8224-99C308717F8DQ33628494-52C7F857-770A-4DF0-A1AE-67CA37076A1FQ33661077-A279EB6C-5C3B-45EC-BC92-3E767E07EC9EQ33668232-3A5C1B09-3577-4E69-8E72-A82111289221Q33679174-86957406-0C2F-474A-A263-40EA9DA3BDEDQ33695400-94F4574B-3B5B-4784-989A-21BF9DA291AD
P2860
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
@en
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
@en-gb
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
@nl
type
label
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
@en
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
@en-gb
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
@nl
prefLabel
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
@en
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
@en-gb
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
@nl
P1476
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.
@en
P2093
Rebecca M Lovell
P304
712-721.e4
P356
10.1016/J.CGH.2012.02.029
P407
P577
2012-03-15T00:00:00Z